These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35349533)

  • 1. Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Bittermann T; Mahmud N; Weinberg EM; Reddy KR
    Transplantation; 2022 Jul; 106(7):1401-1410. PubMed ID: 35349533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving trends and outcomes on the US liver transplant waitlist of alcohol-associated hepatitis patients with very high MELD scores.
    Tanaka T; Axelrod D
    Liver Int; 2024 Sep; 44(9):2102-2107. PubMed ID: 38924203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent.
    Bittermann T; Reddy KR
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2389-2397.e2. PubMed ID: 32971230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant waitlist outcomes in alcoholic hepatitis compared with other liver diseases: An analysis of UNOS registry.
    Kitajima T; Moonka D; Yeddula S; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Nagai S
    Clin Transplant; 2020 May; 34(5):e13837. PubMed ID: 32073688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age added to MELD or ACLF predicts survival in patients with alcohol-associated hepatitis declined for liver transplantation.
    Rutledge SM; Nathani R; Wyatt BE; Eschbach E; Trivedi P; Kerznerman S; Chu L; Schiano TD; Kim-Schluger L; Florman S; Im GY
    Hepatol Commun; 2024 Sep; 8(9):. PubMed ID: 39167426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.
    Lee BP; Samur S; Dalgic OO; Bethea ED; Lucey MR; Weinberg E; Hsu C; Rinella ME; Im GY; Fix OK; Therapondos G; Han H; Victor DW; Voigt MD; Eswaran S; Terrault NA; Chhatwal J
    Gastroenterology; 2019 Aug; 157(2):472-480.e5. PubMed ID: 30998988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
    Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.
    Kim WR; Mannalithara A; Kwo PY; Bonham CA; Kwong A
    Hepatology; 2023 Mar; 77(3):851-861. PubMed ID: 36052665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of neural network models to predict liver transplantation waitlist mortality.
    Nagai S; Nallabasannagari AR; Moonka D; Reddiboina M; Yeddula S; Kitajima T; Francis I; Abouljoud M
    Liver Transpl; 2022 Jul; 28(7):1133-1143. PubMed ID: 35224855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
    Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
    J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
    Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14-Day Waitlist Mortality Than Status-1a Patients.
    Sundaram V; Shah P; Wong RJ; Karvellas CJ; Fortune BE; Mahmud N; Kuo A; Jalan R
    Hepatology; 2019 Jul; 70(1):334-345. PubMed ID: 30908660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
    Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
    Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System.
    Ahn DJ; Zeng S; Pelzer KM; Barth RN; Gallo A; Parker WF
    Transplantation; 2023 Oct; 107(10):e247-e256. PubMed ID: 37408100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA.
    Cholankeril G; Goli K; Rana A; Hernaez R; Podboy A; Jalal P; Da BL; Satapathy SK; Kim D; Ahmed A; Goss J; Kanwal F
    Hepatology; 2021 Dec; 74(6):3316-3329. PubMed ID: 34310738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revising model for end-stage liver disease from calendar-time cross-sections with correction for selection bias.
    de Ferrante HC; van Rosmalen M; Smeulders BML; Vogelaar S; Spieksma FCR
    BMC Med Res Methodol; 2024 Feb; 24(1):51. PubMed ID: 38419019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Yi Z; Mayorga ME; Orman ES; Wheeler SB; Hayashi PH; Barritt AS
    Transplantation; 2017 Oct; 101(10):2368-2374. PubMed ID: 28858174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.